On May 23, Guangxin Biointelligent Manufacturing Technology Innovation (Shenzhen) Co., Ltd. held an unveiling ceremony in Shenzhen. According to reports, Guangxin Biotech was established in September 2023 with a joint investment of 150 million yuan by Xinghu Technology, a subsidiary of Guangxin Group, and Guangdong Guangxin Innovation Research Institute Co., Ltd. According to the plan, Guangxin Biotech will focus on intelligent breeding techniques for industrial strains such as synthetic biology and microbiology to strengthen basic, urgent, cutting-edge, and disruptive technology research and promote the progress of the biotechnology industry. Recently, Guangxin Biotech also signed a “Memorandum of Cooperation” with the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences. The two sides will jointly build a joint laboratory and promote the transformation of achievements and project incubation.
广新生物揭牌并与中国科学院深圳先进技术研究院签约
Guangxin Biotech unveiled and signed a contract with the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.